BPC-157 legal status, as of October 2026
- February 27, 2026: HHS announced that BPC-157 and about a dozen other peptides would move from FDA's Category 2 (restricted) list back to Category 1.
- July 23–24, 2026: FDA's Pharmacy Compounding Advisory Committee voted 8–6 to recommend adding BPC-157 to the 503A bulks list. FDA staff had recommended against it.
- Now: the committee's vote is advisory. FDA has not finalized BPC-157's status, so pharmacies differ on whether they will compound it.
In practice, a licensed prescriber working with a licensed pharmacy is the only party who can tell you whether BPC-157 is available to you today, or recommend an alternative if it isn't. See our regulatory tracker for updates.
Three ways people try to get BPC-157
The clinician evaluates you, orders labs, and if appropriate writes a prescription that a licensed compounding pharmacy fills for you by name. This is the only patient pathway, and the only one with a professional accountable for dose, quality and follow-up.
Sold as “not for human use” to sidestep drug law. There is no prescriber, no pharmacy standard, and no one accountable for what is in the vial.
If nobody licensed evaluates you and no pharmacy is named, it is the research-chemical channel with a storefront.
Telehealth or an in-person clinic?
Telehealth works well for the first consultation, lab review, and follow-ups on a stable protocol. BPC-157 is usually self-injected under the skin after training, so ongoing office visits often aren't needed.
An in-person visit makes more sense when your goal involves a physical exam, such as an acute injury or a complicated orthopedic history, or if you want hands-on injection training.
Telehealth rules are set state by state. The one requirement that applies everywhere: the clinician must be licensed in the state where you are located during the visit.
Questions to ask any BPC-157 provider
- Which pharmacy fills your BPC-157 prescriptions, and is it a licensed 503A pharmacy?
- How do you confirm potency and purity for what you prescribe?
- What baseline labs do you require before starting?
- How do you decide on dose and cycle length for my specific goal?
- What follow-up and lab schedule do you build into the protocol?
- How many patients have you treated with BPC-157, and for what?
- What adverse effects have you seen, and how did you manage them?
Red flags
- Selling BPC-157 without a clinician evaluation or prescription
- Vials labeled "research use only" or "not for human consumption"
- No named pharmacy, or a pharmacy that won't show its state license
- Guaranteed results, or claims that BPC-157 is FDA-approved
- Pressure to buy multi-month bundles before your first visit
How the Peptide Association can help
Instead of a list of clinics, you complete a short intake. A licensed clinician in our network who is licensed in your state reviews it, and decides with you whether BPC-157 is appropriate and available, or whether something else fits better. Nothing is prescribed without that clinician's judgment.
Start the intakePaid referralDisclosure: Peptide Association LLC receives 10% of peptide sales to patients we refer to this provider. This is a paid referral. See exactly how we make money.
Frequently asked questions
For the evidence, dosing frameworks and safety profile, read our clinician's guide to BPC-157. This page is educational and is not medical or legal advice.